Baltrus Victoria sold $10K of OSCR
Baltrus Victoria (Chief Accounting Officer) sold 432 shares of Oscar Health, Inc. (OSCR) at $22.45 on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is explicitly under a pre-arranged Rule 10b5-1 plan, it is generally less informative about near-term business outlook than unscheduled selling.
Market read
Traders may briefly reassess sentiment around OSCR, but the disclosure is unlikely to change the fundamental thesis by itself.
What to watch
Insider sales can be driven by diversification/tax planning; the key signal would be changes in plan size, frequency, or sales outside 10b5-1.
Background
This is an SEC Form 4 insider transaction disclosure (officer: Chief Accounting Officer) for Oscar Health.
Ticker impact
Oscar Health CFO Baltrus Victoria sold 432 shares in an open-market transaction filed as an SEC Form 4 on June 4.
Minimal-to-modest short-term sentiment impact; unlikely to drive a sustained move absent other catalysts.
The filing specifies a Rule 10b5-1 pre-arranged plan, and the disclosed sale size (~$9.7k) is small relative to company scale, reducing fundamental interpretation risk.
Market effects
No clear sector read-through; this is a single-company insider transaction.
None.
None.
Counterpoint
Treat the trade as routine 10b5-1 activity and ignore it unless follow-on filings show a pattern of larger, non-10b5-1 selling.
Key entities
- issuerOscar Health, Inc.
Subject of the insider transaction disclosure; CFO-level officer sold shares under a 10b5-1 plan.
- insiderBaltrus Victoria
Chief Accounting Officer who executed the open-market sale.
